Login / Signup

Upstream therapeutic strategies of valsartan and fluvastatin on hypertensive patients with non-permanent atrial fibrillation.

Zhiqiang ZhaoXiaowei NiuZhaojie DongWenwei QiEnzhao LiuTong LiuLifeng LiYingzi LiangGuangping Li
Published in: Cardiovascular therapeutics (2018)
CCB plus fluvastatin and valsartan can reduce the recurrence rate of non-permanent AF and to delay the progression from non-permanent AF to permanent AF in patients with hypertension. The combined application of valsartan and fluvastatin is more effective than valsartan or CCB alone in the upstream therapies of AF.
Keyphrases